Videos
February 14, 2020
Psych Congress cochair Charles Raison, MD, hosted a Facebook Live event with Melissa Rosenkranz, PhD, titled "Behind the Science: The Mind-Body Connection."
December 19, 2019
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
December 19, 2019
Michael Thase, MD, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
December 19, 2019
Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.
December 13, 2019
Joe Pritchard, CEO of Pinnacle Treatment Centers, discusses how an integrated hub-and-spoke care delivery system allows the organization to be impactful in the communities it enters with regards to…
December 13, 2019
Tani Weiner, JD, shareholder and vice-chair of the behavioral health law group at Polsinelli LLP, and Edith Bauer, Esq., general counsel at Discovery Behavioral Health, discuss issues around…
December 05, 2019
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
November 07, 2019
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
November 01, 2019
In this video, forensic psychiatrist Phillip J. Resnick, MD discusses common traits in school shooters, misconceptions people have about school shooters, and how mental health clinicians can help…
October 28, 2019
Michael Thase, MD, discusses when clinicians should consider using thyroid hormone as an antidepressant augmentation strategy and possible risks of the approach.